Teva Pharmaceutical Industries Ltd (TEVA)
$8.15 0.65 (8.67%)
19:59 EDT TEVA Stock Quote Delayed 15 Minutes
Previous Close $19.70
Market Cap 8.30B
PE Ratio -0.52
Volume (Avg. Vol.) 77.40M
Day's Range 7.50 - 8.95
52-Week Range 6.07 - 23.97
Dividend & Yield 0.07 (0.88%)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries Ltd News
- From InvestorPlace
- From the Web
Another opioid settlement has been reached and earnings season is heating up. Here's what happened in the stock market today.
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
The J&J opioid ruling 2019 for the case in Oklahoma has been decided and it will have the company paying a fine to the state.
Teva, Take-Two, Beyond Meat, PaySign and Sogou were our top stock trades on Tuesday. Here's how to trade them.
The stock charts of Ford, International Paper and LyondellBasell are each knocking on the door of major moves, if traders can take one more step.
Teva Pharmaceuticals (TEVA) stock is down more than 7% to start the week as the company continues to face lawsuits, leading to a downgrade.
These companies are going to have a tough time with the market’s heat, making each of them stocks to sell now.
The stock charts for H&R Block, Philip Morris and Twitter are knocking on the door of some trade-worthy moves.
Options trading was buzzing in Teva Pharmaceuticals, Advanced Micro Devices, and General Electric on Tuesday. Here are the metrics that matter moving forward.
The stock charts of HRL, JNPR and LLY stock are moving into the midpoint of the week on the cusp of something trade-worthy.
Nvidia, American Airlines, Teva, AMD and Gilead Sciences are our top stock trades to watch for Wednesday. See the charts here.
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
Zscaler, Uber, Amazon, Teva and the S&P 500 are our top stock trades to watch going into Tuesday. Buckle up with these charts.
Teva Pharmaceuticals news concerning allegations and a massive price fixing lawsuit are hitting TEVA stock hard on Monday.
Teva stock is only getting lukewarm love from analysts, but tacitly, these pros may be more optimistic than they're letting on.
TEVA stock has multiple headwinds, including high debt and weakeneing Copaxone sales. But TEVA should benefit from promising new products.
From The Street
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!